ir.progenics.comInvestor Relations | Progenics Pharmaceuticals, Inc.

ir.progenics.com Profile

ir.progenics.com

Title:Investor Relations | Progenics Pharmaceuticals, Inc.

Description：The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Discover ir.progenics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

ir.progenics.com Information

Website / Domain:	ir.progenics.com
HomePage size:	33.701 KB
Page Load Time:	0.211326 Seconds
Website IP Address:	184.50.88.76
Isp Server:	Akamai Technologies Inc.

ir.progenics.com Ip Information

Ip Country:	United States
City Name:	San Jose
Latitude:	37.339389801025
Longitude:	-121.89495849609

ir.progenics.com Keywords accounting

Keyword	Count

ir.progenics.com Httpheader

Accept-Ranges: bytes
Content-Encoding: gzip
Content-Language: en
Content-Type: text/html; charset=UTF-8
device: desktop
ETag: "1592925121"
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation"
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same
Last-Modified: Tue, 23 Jun 2020 15:12:01 GMT
Link: http://ir.progenics.com/; rel="shortlink", http://ir.progenics.com/; rel="canonical", https://ir.progenics.com/investor-relations; rel="alternate"; hreflang="en", https://ir.progenics.com/investor-relations; rel="revision"
Referrer-Policy: no-referrer-when-downgrade
Server: nginx
X-Age: 1533
X-Cache-Hits: 6
X-Content-Type-Options: nosniff
X-Drupal-Dynamic-Cache: UNCACHEABLE
X-Frame-Options: SAMEORIGIN
X-Generator: Drupal 8 (https://www.drupal.org)
X-Request-ID: v-e3ab20dc-b563-11ea-881d-47e3a54c8f36
X-UA-Compatible: IE=edge
X-XSS-Protection: 1; mode=block
Content-Length: 9101
X-EdgeConnect-MidMile-RTT: 46, 46
X-EdgeConnect-Origin-MEX-Latency: 32, 32
Cache-Control: public, max-age=0, s-maxage=1800
Expires: Tue, 23 Jun 2020 15:37:35 GMT
Date: Tue, 23 Jun 2020 15:37:35 GMT
Connection: keep-alive
Vary: Accept-Encoding
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly
Strict-Transport-Security: max-age=15768000 ; preload

ir.progenics.com Meta Info

charset="utf-8"/
content="Progenics Pharmaceuticals, Inc." property="og:site_name"/
content="noindex, nofollow" name="robots"/
content="website" property="og:type"/
content="The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/
content="https://ir.progenics.com/investor-relations" property="og:url"/
content="Investor Relations \| Progenics Pharmaceuticals, Inc." property="og:title"/
content="no-referrer" name="referrer"/
content="The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/
content="Drupal 8 (https://www.drupal.org)" name="Generator"/
content="width" name="MobileOptimized"/
content="true" name="HandheldFriendly"/
content="width=device-width, initial-scale=1.0" name="viewport"/
content="width=device-width, initial-scale=0.382" name="viewport"/

184.50.88.76 Domains

Domain	WebSite Title

ir.progenics.com Similar Website

Domain	WebSite Title
investor.regeneron.com	Investor Relations \| Regeneron Pharmaceuticals Inc.
newsroom.regeneron.com	Investor Relations \| Regeneron Pharmaceuticals Inc.
investors.amneal.com	Amneal Pharmaceuticals Inc - Investor Relations
investor.enzon.com	Investor Relations \| Enzon Pharmaceuticals
ir.alexion.com	Investor Relations \| Alexion Pharmaceuticals, Inc.
investors.vrtx.com	Investor Relations \| Vertex Pharmaceuticals
investor.eagleus.com	Eagle Pharmaceuticals Investor Center \|
ir.progenics.com	Investor Relations \| Progenics Pharmaceuticals, Inc.
ir.supernus.com	Investor Relations - Supernus Pharmaceuticals
investor.sppirx.com	Investor Relations - Spectrum Pharmaceuticals, Inc.
investors.aeriepharma.com	Investor Relations \| Aerie Pharmaceuticals, Inc
ir.titanpharm.com	Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP)
investor.ligand.com	Investor Summary :: Ligand Pharmaceuticals Incorporated (LGND)
zuchepharma.trustpass.alibaba.com	ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices
aeriepharma.com	Aerie Pharmaceuticals \| Leading Ophthalmic Pharmaceuticals

ir.progenics.com Traffic Sources Chart

ir.progenics.com Alexa Rank History Chart

ir.progenics.com Html To Plain Text

Skip to main navigation Progenics Pharmaceuticals, Inc. is now a subsidiary of Lantheus Holdings, Inc. 646-975-2500 Contact Us Pipeline Approved Products AZEDRA – Ultra-Orphan Radiotherapeutic In Development PyL – PSMA Targeted PET Imaging Agent 1404 – PSMA Targeted Imaging 1095 – Small Molecule Therapeutic Clinical Trials Investors Investors Overview Proxy Materials Financial Information/Reports SEC Filings Quarterly Results Press Releases Business Development Overview Become A Partner About Us Vision Management Team Board of Directors Compliance Program Careers Contact Us Investors Investor Relations Overview Proxy Materials Financial Information/Reports MORE> Investor Relations Investor Relations Progenics is proud to have joined the Lantheus family. Lantheus, a global leader in the field of medical imaging, develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. These pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging. We are pleased to add three commercial products and a pipeline of therapeutic agents and PSMA-targeted imaging agents to the Lantheus portfolio. To learn more about investor relations, please click here . View all » Recent Releases Jun 22, 2020 Summary Toggle Lantheus Completes Merger with Progenics Jun 16, 2020 Summary Toggle Progenics Stockholders Approve Merger with Lantheus Contact Us Privacy Policy Legal Notice Compliance Trademarks, registered or otherwise, are the property of their respective owner. © 2020 Lantheus Holdings, Inc. All rights reserved. Intended for U.S. Residents only. 331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668 Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy ....

ir.progenics.com Whois

"domain_name": "PROGENICS.COM", "registrar": "Network Solutions, LLC", "whois_server": "whois.networksolutions.com", "referral_url": null, "updated_date": [ "2019-09-09 07:34:47", "2020-07-28 07:56:05" ], "creation_date": "1997-11-09 05:00:00", "expiration_date": "2024-11-08 05:00:00", "name_servers": [ "NS1.HVDATA.NET", "NS2.HVDATA.NET" ], "status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "emails": [ "abuse@web.com", "ww3w65qq33n@networksolutionsprivateregistration.com" ], "dnssec": "unsigned", "name": "PERFECT PRIVACY, LLC", "org": null, "address": "5335 Gate Parkway care of Network Solutions PO Box 459", "city": "Jacksonville", "state": "FL", "zipcode": "32256", "country": "US"